Selective vitamin D receptor activation was proven to lower proteinuria in patients with DKD (238); it was later demonstrated that vitamin D3 analogs might ameliorate podocyte injury by reversing the decrease in nephrin expression induced by hyperglycemia (239–241). This evidence concerns the gene NPHS1 and Hyperglycemia.